Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04263532 · ClinicalTrials.gov registry record
Vector Efficacy Cross-Over Pilot Study
A clinical trial, sponsored by Philips Clinical & Medical Affairs Global.
- Terminated
- Registry status
- 21
- Enrollment target
NCT04263532 is a clinical trial that was terminated before completion, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 21 participants.
The verdict
NCT04263532 was terminated before completion, sponsored by Philips Clinical & Medical Affairs Global.
- TERMINATED
- Registry status
- 21 participants
- Enrollment target
Study Summary
The study evaluates the safety and efficacy of the modified Bi-level positive airway pressure (BiPAP) A40 with Vector Algorithm to treat Chronic Obstructive Pulmonary Disease (COPD) patients with excessive carbon dioxide in their bloodstream (hypercapnia) and expiratory flow limitation (EFL), a constriction of the lower airways. The study will include current users of non-invasive ventilation (NIV) as well as those who are not currently using an NIV device.
Interventions
- DEVICE Modified BiPAP A40 with Vector Algorithm (Vector)
- DEVICE Modified BiPAP A40 with Standard of Care Settings
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2020-01-21 |
| Est. Completion | 2023-11-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04263532
The ClinicalTrials.gov registry entry for NCT04263532 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Clinical & Medical Affairs Global, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Modified BiPAP A40 with Vector Algorithm (Vector) is the first listed.
NCT04263532 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04263532 about?
NCT04263532 is a clinical study titled "Vector Efficacy Cross-Over Pilot Study". The study evaluates the safety and efficacy of the modified Bi-level positive airway pressure (BiPAP) A40 with Vector Algorithm to treat Chronic Obstructive Pulmonary Disease (COPD) patients with excessive carbon dioxide in their bloodstream (hypercapnia) and expiratory flow limitation (EFL), a cons...
What is the current status of trial NCT04263532?
This trial is currently terminated. The enrollment target is 21 participants. The study started on 2020-01-21. Estimated completion is 2023-11-17.
What interventions are being tested in trial NCT04263532?
The interventions under investigation include: Modified BiPAP A40 with Vector Algorithm (Vector) (DEVICE), Modified BiPAP A40 with Standard of Care Settings (DEVICE).
Who is sponsoring clinical trial NCT04263532?
This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.